Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: comparative analysis of the Macdonald, RECIST, RANO, and RECIST + F criteria

Traditionally, the most widely used criteria for response assessment in glioblastoma have been Macdonald and the Response Evaluation Criteria In Solid Tumors (RECIST). Recently, new criteria addressing contrast enhancement and fluid-attenuated inversion recovery (FLAIR)/T2 hyperintensity have been d...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Pérez-Larraya, Jaime Gállego, Lahutte, Marion, Petrirena, Gregorio, Reyes-Botero, Germán, González-Aguilar, Alberto, Houillier, Caroline, Guillevin, Rémy, Sanson, Marc, Hoang-Xuan, Khê, Delattre, Jean-Yves
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2012
Soggetti:
Clinical Investigations
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3337315/
https://ncbi.nlm.nih.gov/pubmed/22492961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nos070
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi